Search | TVST | ARVO Journals

Showing 1 – 20 of 74

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2024

Novel Quinoline Substituted Autophagy Inhibitors Attenuate Zika Virus Replication in Ocular Cells

Sneha Singh; Faraz Ahmad; Hariprasad Aruri; Susmita Das; Prahlad Parajuli; Navnath S Gavande; Pawan Kumar Singh; Ashok Kumar

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):1988.

ARVO Annual Meeting Abstract June 2024

Nanoparticles targeting ferroptosis: A Novel Therapy for Bacterial Endophthalmitis

Zeeshan Ahmad; Henry V Kolge; Sukhvinder Singh; Ashok Kumar

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):2099.

ARVO Annual Meeting Abstract June 2024

Silver nanoparticles synergize with antibiotics to enhance antimicrobial activity against ocular pathogens

Henry V Kolge; Zeeshan Ahmad; Susmita Das; Sukhvinder Singh; Ashok Kumar

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5624.

ARVO Annual Meeting Abstract June 2024

Staphylococcus aureus (SA) metallophores contribute to virulence in inducing endophthalmitis

Susmita Das; Ashok Kumar

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5613.

ARVO Annual Meeting Abstract June 2024

Itaconate ameliorates autoimmune uveitis by modulating Th17/Treg cell imbalance via metabolic reprogramming

Sukhvinder Singh; Ashok Kumar

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):5071.

ARVO Annual Meeting Abstract June 2024

Molecular and cellular basis of Zika virus-induced ocular pathology

Ashok Kumar

Invest. Ophthalmol. Vis. Sci.. 2024; 65(7):6130.

ARVO Annual Meeting Abstract June 2023

Topical anesthetic gel interferes with antibacterial efficacy of povidone-iodine both in vitro and in vivo

Cecilly Kelleher; Jacob Im; Linda Kang; Aleksey Mishulin; Sukhvinder Singh; Ashok Kumar

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):602.

ARVO Annual Meeting Abstract June 2023

Metabolic Profiling of Aqueous Humor from Glaucoma Patients Identifies Potential Therapeutic Target for Neuroprotection

Pawan Kumar Singh; Nariman Nassiri; Sarah Syeda; Vaama Patel; Shibandri Das; Mamta Kanwar; Bret A. Hughes; Mark S Juzych; Ashok Kumar

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):1581.

ARVO Annual Meeting Abstract June 2023

SARS-CoV-2 Spike (S) protein activates retinal endothelial and innate immune cells to cause thrombosis in retinal blood vessels

Sneha Singh; Ashok Kumar

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3797.

ARVO Annual Meeting Abstract June 2023

Parthanatos: A new way of retinal cell death in endophthalmitis

Zeeshan Ahmad; Sukhvinder Singh; Ashok Kumar

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):3792.

ARVO Annual Meeting Abstract June 2023

Activation of Pyruvate Kinase M2 (PKM2) attenuates inflammatory response in experimental bacterial endophthalmitis

Sukhvinder Singh; Zeeshan Ahmad; Susmita Das; Ashok Kumar

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4378.

ARVO Annual Meeting Abstract June 2023

S-nitrosoglutathione (GSNO) ameliorates severity of experimental Staphylococcus aureus endophthalmitis

Susmita Das; Zeeshan Ahmad; Sukhvinder Singh; Sneha Singh; Ashok Kumar

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4373.

ARVO Annual Meeting Abstract June 2023

Metabolomics in the discovery of new therapeutic targets for ocular infectious diseases

Ashok Kumar

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):4759.

ARVO Annual Meeting Abstract June 2022

Lipid peroxidation and iron accumulation induced ferroptosis in bacterial endophthalmitis

ZEESHAN AHMAD; Sukhvinder Singh; Xavier Walker; Robert Wright; Ashok Kumar

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):855.

ARVO Annual Meeting Abstract June 2022

Adenosine treatment ameliorates bacterial endophthalmitis by promoting antimicrobial activity and inhibiting inflammatory milieu

Sukhvinder Singh; ZEESHAN AHMAD; Susmita Das; Ashok Kumar

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1095.

ARVO Annual Meeting Abstract June 2022

Drug repurposing identified non-antibiotic drugs for the treatment of Staphylococcal endophthalmitis

Susmita Das; Beena Thomas; Sukhvinder Singh; riya sachdeva; manoj bhasin; Ashok Kumar

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1678 – A0508.

ARVO Annual Meeting Abstract June 2022

Differential innate immune response and replication of SARS-CoV-2 in human diabetic corneal epithelial cells

Sneha Singh; Gustavo Garcia; Ruchi Shah; Andrei A Kramerov; Alokkumar Jha; Vaithilingaraja Arumugaswami; Alexander V Ljubimov; Ashok Kumar

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1670 – A0500.

ARVO Annual Meeting Abstract June 2022

Role of Zika virus (ZIKV) in Glaucoma Pathobiology

Pawan Kumar Singh; Ramesh B Kasetti; Gulab Zode; Ashok Kumar

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2856 – A0379.

Articles August 2021

Multidrug-Resistant Pseudomonas aeruginosa Triggers Differential Inflammatory Response in Patients With Endophthalmitis

PDF

Poonam Naik; Sukhvinder Singh; Dhanwini Rudraprasad; Vivek Pravin Dave; Ashok Kumar; Joveeta Joseph
TAGS: endophthalmitis, inflammatory response, pseudomonas aeruginosa, precipitating factors, inflammation mediators, cytokine
Trans. Vis. Sci. Tech.. 2021; 10(9):26. https://doi.org/10.1167/tvst.10.9.26

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2021

Resolvin D1 (RvD1) as an Adjunct Anti-inflammatory Therapy to Treat Bacterial Endophthalmitis.

Pawan Kumar Singh; Sukhvinder Singh; Ashok Kumar

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):405.

1 2 3 4

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Novel Quinoline Substituted Autophagy Inhibitors Attenuate Zika Virus Replication in Ocular Cells

Nanoparticles targeting ferroptosis: A Novel Therapy for Bacterial Endophthalmitis

Silver nanoparticles synergize with antibiotics to enhance antimicrobial activity against ocular pathogens

Staphylococcus aureus (SA) metallophores contribute to virulence in inducing endophthalmitis

Itaconate ameliorates autoimmune uveitis by modulating Th17/Treg cell imbalance via metabolic reprogramming

Molecular and cellular basis of Zika virus-induced ocular pathology

Topical anesthetic gel interferes with antibacterial efficacy of povidone-iodine both in vitro and in vivo

Metabolic Profiling of Aqueous Humor from Glaucoma Patients Identifies Potential Therapeutic Target for Neuroprotection

SARS-CoV-2 Spike (S) protein activates retinal endothelial and innate immune cells to cause thrombosis in retinal blood vessels

Parthanatos: A new way of retinal cell death in endophthalmitis

Activation of Pyruvate Kinase M2 (PKM2) attenuates inflammatory response in experimental bacterial endophthalmitis

S-nitrosoglutathione (GSNO) ameliorates severity of experimental Staphylococcus aureus endophthalmitis

Metabolomics in the discovery of new therapeutic targets for ocular infectious diseases

Lipid peroxidation and iron accumulation induced ferroptosis in bacterial endophthalmitis

Adenosine treatment ameliorates bacterial endophthalmitis by promoting antimicrobial activity and inhibiting inflammatory milieu

Drug repurposing identified non-antibiotic drugs for the treatment of Staphylococcal endophthalmitis

Differential innate immune response and replication of SARS-CoV-2 in human diabetic corneal epithelial cells

Role of Zika virus (ZIKV) in Glaucoma Pathobiology

Multidrug-Resistant Pseudomonas aeruginosa Triggers Differential Inflammatory Response in Patients With Endophthalmitis

Resolvin D1 (RvD1) as an Adjunct Anti-inflammatory Therapy to Treat Bacterial Endophthalmitis.

To View More...

You must be signed into an individual account to use this feature.